Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 30, 2026
Helping T cells find cancers hiding in plain sight
From the Chapuis Lab, Translational Science and Therapeutics Division
Dr. Rahul Banerjee on the future of myeloma care
Oncology Insights with Dr. Petros Grivas - Episode 25
How targeted radiation reshapes the bone marrow
From the Termini Lab, Translational Science and Therapeutics Division
Oncology Insights with Dr. Petros Grivas - Episode 12
Dr. Stanley Riddell traces his journey from bone marrow transplantation to CAR T-cell therapies in a new podcast episode
Is there a way to boost immunotherapy response?
American Cancer Society grant will fund new analysis of how advanced melanoma evades the immune system
Oncology Insights with Dr. Petros Grivas - Episode 11
Inside the science changing lung cancer treatment
Oncology Insights with Dr. Petros Grivas - Episode 10
Inside the world of immunotherapy: innovations and access strategies with Dr. Mazyar Shadman
Dr. Soheil Meshinchi, a leading expert in acute myeloid leukemia, named Dylan Burke Endowed Chair in Immunotherapy
Meshinchi’s research training the body to fight cancer is expanding from blood cancers to solid tumors
For many blood cancer patients, CAR T-cell therapy is game-changing
In this episode of From Bench to Bedside and Beyond, Dr. Mazyar Shadman explains why CAR T-cell therapy should be considered for patients who relapse
Delivering the best possible cancer care
Chief medical officer Tom Purcell emphasizes the importance of improving the patient experience
Fred Hutch study finds new life for ‘ineffective’ drugs
Innovative method using more authentic tumor samples reveals untapped potential for drugs written off by more conventional tests
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response
A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments